Impact of time-of-day administration of immune checkpoint inhibitors on survival outcomes in patients with recurrent/metastatic head and neck cancer (R/M HNSCC): a retrospective cohort study
作者
Paulien Van Loocke,Benoit Beuselinck,Jeroen Meulemans,Sandra Nuyts,Robin Willaert,Davide Di Santo,Esther Hauben,Robert Hermans,Abhishek D. Garg,Vincent Vander Poorten,Oliver Bechter,Paul M. Clément